IMMUNOFLUORESCENCE STAINING OF RENAL BIOPSY SAMPLES IN PATIENTS WITH DIABETIC NEPHROPATHY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS USING MONOCLONAL-ANTIBODY TO REDUCED GLYCATED LYSINE
D. Suzuki et al., IMMUNOFLUORESCENCE STAINING OF RENAL BIOPSY SAMPLES IN PATIENTS WITH DIABETIC NEPHROPATHY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS USING MONOCLONAL-ANTIBODY TO REDUCED GLYCATED LYSINE, Journal of diabetes and its complications, 10(6), 1996, pp. 314-319
This is the first report on immunofluorescence staining of renal biops
y samples in human diabetic nephropathy (DN) using monoclonal antibodi
es to reduced glycated lysine. In order to detect the localization of
glycated lysine in the mesangial matrix and/or the glomerular basement
membrane (GBM), we examined immunofluorescence staining using antibod
ies against reduced glycated lysine in the glomeruli of 16 patients wi
th DN and ten age-matched patients with diffuse mesangial proliferativ
e glomerulonephritis without IgA deposition (DPGN) as controls. In the
early stage of DN, immunofluorescence microscopy revealed the presenc
e of intense staining for reduced glycated lysine in the GEM as well a
s in part of the tubular basement membrane, but not in the mesangial a
rea. In contrast, immunofluorescence microscopy revealed less staining
for glycated lysine in the GBM in the advanced stage of DN, and no re
action with any part of the renal tissue in patients with DPGN. It was
concluded that detection of reduced glycated lysine in GBM in the ear
ly stage of DN might be associated with the initial pathogenesis of th
is disease. (C) Elsevier Science Inc., 1996.